Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Naofumi Ono"'
Autor:
Tomoya Sano, Tatsuya Ide, Shirachi Miki, Teruko Hino, Naofumi Ono, Takuji Torimura, Toshihiro Kawaguchi, Reiichiro Kuwahara, Keisuke Amano
Publikováno v:
Molecular and Clinical Oncology
Advanced liver fibrosis is the most important risk factor for hepatocellular carcinoma (HCC) development after achieving sustained virological response (SVR) by direct-acting antiviral (DAA) treatment in patients with chronic hepatitis C. Wisteria fl
Autor:
Naofumi Ono, Hideyuki Hyogo, Yuichiro Eguchi, Toshiji Saibara, Takahisa Eguchi, Hirokazu Takahashi, Kazuma Fujimoto, Masafumi Ono, Yoichiro Kitajima, Chika Tsuji, Kazuaki Chayama, Keizo Anzai
Publikováno v:
Journal of Gastroenterology. 50:1114-1123
Fatty liver is an important clinical feature not only in alcoholic and non-alcoholic fatty liver diseases, but in other chronic liver diseases as well. Our aim was to elucidate the effect and relationship between habitual alcohol intake and obesity i
Autor:
Norimasa Araki, Miyuki Yamaguchi, Takahisa Eguchi, Keizo Anzai, Motoyasu Kojima, Kenichi Tanaka, Masafumi Ono, Yayoi Matsuda, Yasushi Ide, Taiga Otsuka, Naofumi Ono, Yuichiro Eguchi, Yoichiro Kitajima, Hirokazu Takahashi, Iwata Ozaki, Hideyuki Hyogo
Publikováno v:
Hepatology Research. 45:269-278
Aim Non-alcoholic fatty liver disease (NAFLD), a hepatic manifestation of metabolic syndrome, is associated with an increased risk of developing lifestyle-related diseases including type 2 diabetes, cardiovascular disease and cerebral vessel disease.
Autor:
Kazuaki Chayama, Yoichiro Kitajima, Kenichi Tanaka, Hirokazu Takahashi, Yuichiro Eguchi, Keizo Anzai, Takahisa Eguchi, Hideyuki Hyogo, Toshiji Saibara, Naofumi Ono, Kazuma Fujimoto, Masafumi Ono
Publikováno v:
Hepatology Research. 44:1196-1207
Aim Serum alanine aminotransferase (ALT) is important for screening, diagnosis and management of chronic liver diseases. The incidence of non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH), which is considered a hepatic ma
Autor:
Yuichiro Eguchi, Kenichi Tanaka, Naofumi Ono, Toshihiko Mizuta, Kazuma Fujimoto, Takahisa Eguchi, Yuki Kimura, Hideyuki Hyogo, Keizo Anzai, Takuya Kuwashiro, Yoshio Sumida, Yoichiro Kitajima, Hirokazu Takahashi, Iwata Ozaki
Publikováno v:
Journal of Gastroenterology and Hepatology. 28:1507-1514
Background and Aims The pathogenesis of non-alcoholic fatty liver disease (NAFLD) is now focusing on its organ cross-talk with not only adipose tissue but also systemic skeletal muscle. Cross-sectional and longitudinal studies were conducted to deter
Autor:
Noriko Oza, Toshihiko Mizuta, Yuichiro Eguchi, Naofumi Ono, Shunya Nakashita, Hirokazu Takahashi, Yasunori Kawaguchi, Takahisa Eguchi, Eriko Ishibashi, Takuya Kuwashiro, Kazuma Fujimoto, Iwata Ozaki, Shinji Iwane, Keizo Anzai, Yoichiro Kitajima
Publikováno v:
Hepatology Research. 44:812-817
Aim To investigate the efficacy of ezetimibe and lifestyle intervention for treating patients with non-alcoholic fatty liver disease (NAFLD) and residual dyslipidemia via a combination of ezetimibe and lifestyle intervention. Methods Patients with NA
Autor:
Yuichiro Eguchi, Hirokazu Takahashi, Kenichi Tanaka, Yoichiro Kitajima, Seiji Kawazoe, Naofumi Ono, Kenichiro Murayama, Shinji Iwane, Takahisa Eguchi, Keizo Anzai, Takuya Kuwashiro, Takumi Akiyama
Publikováno v:
Journal of gastroenterology. 53(3)
Liver cirrhosis induces marked metabolic disorders, protein-energy malnutrition, and sarcopenia. The objective of the study reported here was to investigate the effects of dietary branched-chain amino acids (BCAAs) on systemic glucose metabolism, ske
Autor:
Naofumi Ono, Jsg-Nafld, Kazuma Fujimoto, Masafumi Ono, Toshihiko Mizuta, Hideyuki Hyogo, Toshiji Saibara, Yuichiro Eguchi, Kazuaki Chayama
Publikováno v:
Journal of Gastroenterology. 47:586-595
The prevalence of nonalcoholic fatty liver disease (NAFLD) has been increasing. This study aimed to assess the recent prevalence of NAFLD and to predict the prevalence of nonalcoholic steatohepatitis (NASH) with liver fibrosis using established scori
Autor:
Yuichiro Eguchi, Takahisa Eguchi, Yasutomo Oda, Toshihiko Mizuta, Yoshio Sumida, Keizo Anzai, Takaya Tashiro, Hiroshi Isoda, Yoichiro Kitajima, Eriko Ishibashi, Eri Iwamoto, Takuya Kuwashiro, Yasunori Kawaguchi, Hirokazu Takahashi, Shu Soejima, Iwata Ozaki, Ryuichi Iwakiri, Kazuma Fujimoto, Shunzo Koizumi, Sei Emura, Naofumi Ono, Hiroko Horie
Publikováno v:
Journal of Gastroenterology. 46:70-78
Our previous studies have indicated a close association between visceral fat accumulation and hepatic steatosis in nonalcoholic fatty liver disease (NAFLD). This study investigated whether visceral fat accumulation was related to the pathogenesis and
Autor:
Shuji Toda, Eriko Ishibashi, Shigehisa Aoki, Shunya Nakashita, Takahisa Eguchi, Yoichiro Kitajima, Naofumi Ono, Kazuma Fujimoto, Ryuichi Iwakiri, Iwata Ozaki, Kohei Arai, Toshihiko Mizuta, Yuichiro Eguchi
Publikováno v:
Journal of Gastroenterology. 45:218-224
Although nonalcoholic fatty liver disease (NAFLD) is associated with visceral obesity, the relationship between visceral fat accumulation and skeletal muscle steatosis in patients with NAFLD has not been established. We evaluated: (1) the relationshi